Health recommendations from study on aspirin and lung cancer are premature

June 27, 2002

An epidemiological study published earlier this week in the British Journal of Cancer by NYU School of Medicine researchers shows an association between regular use of aspirin and reduced risk of a common type of lung cancer in women. But the NYU researchers emphasized today that until large clinical trials establish aspirin's beneficial effect, women shouldn't start taking the painkiller to prevent cancer.

"The results of our study suggest that aspirin may have even wider benefits than previously thought," says Arslan Akhmedkhanov, M.D., Assistant Professor of Obstetrics and Gynecology at NYU School of Medicine, one of the study's authors. "However, we consider our results preliminary. Larger studies are needed to confirm our study's results before any recommendations about aspirin use for the prevention of lung cancer can be made," he says.

The new study found that taking aspirin three or more times each week for at least six months appears to substantially lower a woman's risk of developing non-small cell lung cancer, the most common type of lung cancer. The study involved 81 women with lung cancer who were compared to 808 healthy women of the same age and menopausal status. The women responded to questions about their use of painkillers as part of an ongoing, long-term study called the NYU Women's Health Study (WHS). The WHS began in the late 1980s and was originally designed to evaluate the effects of hormones and diet on breast cancer and was later expanded to other cancers.

From 1994 to 1996, the researchers collected information on aspirin use for women enrolled in the WHS. Follow-up information on aspirin use was obtained from questionnaires distributed between 1994 and 1996.

It isn't known how aspirin could act to lower cancer risk. By reducing local inflammation, aspirin may be preventing the release of certain molecules that stimulate mutations in epithelial cells leading to out-of-control cellular growth, says Dr. Akhmedkhanov. There is some evidence from animal studies that chronic inflammation could be related to the development of cancers arising in the epithelium, the cellular lining, of organs.

Women should not begin taking aspirin to prevent lung cancer, cautions Dr. Akhmedkhanov. Aspirin can cause gastrointestinal bleeding and raise the risk of other bleeding disorders, especially in those with a family history of bleeding disorders. The exact dose of aspirin that should be taken also needs to be determined. Any woman who decides to take aspirin routinely should first consult her primary care physician, he advises.

"Aspirin definitely has side effects," says Dr. Akhmedkhanov. "By far, the best way to avoid lung cancer is to not smoke," he says.
-end-


NYU Langone Medical Center / New York University School of Medicine

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.